Effector Therapeutics Inc (EFTR) Return on Assets ROA from the first quarter of 2024 to first quarter of 2023 and for the year 2024, Average High and Low, Fundamental Ratios from Mar 31 2024 to Mar 31 2023 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Effector Therapeutics Inc   (NASDAQ: EFTR)


Effector Therapeutics Inc 's ROA from the first quarter of 2024 to the first quarter of 2023 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Effector Therapeutics Inc 's ROA in the first quarter of 2024?
Effector Therapeutics Inc recorded a cumulative net loss of $-35 million during 12 months ending in the first quarter of 2024, resulting in a negative return on assets (ROA) of -146.24%.

However, within the Healthcare sector 934 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Mar 31 2024 quarter, so far to 4875, from total ROA ranking in the fourth quarter of 2023 at 5649.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter
Y / Y Total Assets Change 23.73 % -29.35 % -44.99 % -38.14 % -55.69 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -35 -36 -36 -37 -36
Return On Assets (TTM) -146.24 % -160.01 % -146.62 % -129.89 % -109.05 %
EFTR's Total Ranking # 4875 # 5649 # 5071 # 5121 # 5205
Total Assets (TTM) in million 27 21 20 27 22
Seq. Total Assets Change 32.06 % 1.9 % -25.02 % 22.62 % -24.59 %
Seq. Net Income Change - - - - -

EFTR's 5 Years Annual ROA >> Back to EFTR Management Effectiveness >> Compare EFTR ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 445
Sector # 935
Overall # 4786

Return On Assets Statistics
High Average Low
40.45 %
-66.95 %
-160.01 %
(Mar 31 2022)   (Dec 31 2023)



  News about Effector Therapeutics Inc Return on Assets ROA

eFFECTOR Therapeutics Faces Delisting and Wind Down amidst Financial Struggles

eFFECTOR Therapeutics Announces Wind Down and Delisting from Nasdaq
eFFECTOR Therapeutics, a biotechnology company based in Solana Beach, California, has made the decision to terminate its employees and wind down its operations. The company also plans to explore potential strategic alternatives for its development programs. This significant move was decided upon during a special meeting of the board of directors.
In addition to these plans, eFFECTOR Therapeutics has disclosed that its securities currently do not meet the continued listing requirements of the Nasdaq Stock Market. As a result, the company s securities are expected to be delisted if compliance with the requirements is not regained within the necessary timeframe. Anticipating this outcome, eFFECTOR Therapeutics intends to voluntarily request the delisting of its securities, with expectations of the delisting occurring in the near future.



Financial Statements
Effector Therapeutics Inc 's Assets $ 27 million EFTR's Balance sheet
Effector Therapeutics Inc 's Income $ -9 million Quarterly EFTR's Income Statement
EFTR's Income by Division See EFTR's Income by Division



Annual Return On Assets (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
FY
FY
Y / Y Total Assets Change -29.35 % -46.21 % - - -
Total Assets in million 21 29 54 0 0
Y / Y Net Income Change - - - - -
Net Income in million -36 -23 16 0 0
Annual Return On Assets -174.31 % -77.95 % 29.23 % - -

EFTR's 5 Years Annual ROA >> Back to EFTR Management Effectiveness >> Compare EFTR ROA to its Competitors



More Return On Assets Ratios
EFTR's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
EFTR's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for EFTR's Competitors
Subscribers only: Roa for Effector Therapeutics Inc 's Suppliers
Subscribers only: Return On Assets for EFTR's Customers

You may also want to know
EFTR's Roi EFTR's Inventory Turnover Ratio EFTR's Growth Rates EFTR's Dividend Comparisons
EFTR's Profitability Ratios EFTR's Asset Turnover Ratio EFTR's Dividend Growth
EFTR's Roe EFTR's Valuation Ratios EFTR's Financial Strength Ratios EFTR's Dividend Payout Ratio



Companies with similar Return On Assets at Mar 31 2024, within Healthcare Sector ROA

Date modified: 2026-09-26T07:39:44+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.